Sandown, NH, United States of America

Britt Kostraba

This inventor holds 10 USPTO granted patents and 2 published patent applications. Top assignee: Scpharmaceuticals Inc.. Active years: 2022-2025.

USPTO Granted Patents = 10 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Britt Kostraba: Innovator in Pharmaceutical Formulations

Introduction

Britt Kostraba is a notable inventor based in Sandown, NH (US), recognized for his contributions to the field of pharmaceutical formulations. With a total of 10 patents, Kostraba has made significant advancements in the development of concentrated liquid medications.

Latest Patents

Among his latest patents, Kostraba has developed concentrated liquid pharmaceutical formulations of furosemide. These formulations include furosemide or a pharmaceutically acceptable salt, combined with one or more excipients and a buffer. His work also encompasses methods for treating conditions such as congestion, edema, fluid overload, or hypertension in patients requiring such interventions.

Career Highlights

Kostraba's career is marked by his innovative approach to pharmaceutical development. His work at Scpharmaceuticals Inc. has positioned him as a key player in the industry, focusing on improving patient outcomes through effective medication delivery systems.

Collaborations

Kostraba collaborates with talented professionals in his field, including Alfredo Grossi and Shannon Terry. These partnerships enhance the research and development efforts at Scpharmaceuticals Inc., fostering an environment of innovation.

Conclusion

Britt Kostraba's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical science. His innovative patents and collaborative efforts continue to impact the healthcare industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…